Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 27, 2024 06:04 ET | Source: Research and Markets

Antiemetic Drugs Strategic Research Report 2024-2030: Pharmacogenomics and Personalized Medicine Shape the Future of Developments, Rising Cancer Rates and Chemotherapy Demand Fuel Expansion

Dublin, Aug. 27, 2024 (GLOBE NEWSWIRE) -- The "Antiemetic Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Antiemetic Drugs...
April 17, 2024 10:55 ET | Source: Research and Markets

The World Market for Antiemetics to 2030: Featuring Profiles of Abbott Labs, Benuvia Therapeutics, Cipla, Dr. Reddy's Labs, Eisai, and More

Dublin, April 17, 2024 (GLOBE NEWSWIRE) -- The "Antiemetic Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.The global...
November 06, 2020 07:28 ET | Source: Research and Markets

10 Year Forecasts for the Postoperative Nausea and Vomiting (PONV) Market

Dublin, Nov. 06, 2020 (GLOBE NEWSWIRE) -- The "Postoperative nausea and vomiting (PONV) - Market Insights, Epidemiology, and Market Forecast - 2028" drug pipelines has been added to...
July 28, 2020 09:35 ET | Source: RedHill Biopharma Ltd.

RedHill Biopharma Publishes Positive IBS-D Phase 2 Study Data in The American Journal of Gastroenterology

Publication of the Phase 2 U.S. study data show that RHB-102 (Bekinda®) 12mg delivers a clinically meaningful improvement in overall stool consistency response versus placebo in patients with...
December 30, 2015 02:00 ET | Source: Midatech Pharma PLC

Midatech Completes Acquisition of Zuplenz®

OXFORDSHIRE, United Kingdom, Dec. 30, 2015 (GLOBE NEWSWIRE) -- Midatech Pharma (“Midatech” or the “Company” or the “Group”) (AIM:MTPH) (Nasdaq:MTP), the international specialty pharmaceutical...
March 02, 2015 07:00 ET | Source: RedHill Biopharma Ltd.

Positive Bioavailability Studies of RedHill's BEKINDA(TM) to be Presented at the 2015 American Society for Clinical Pharmacology and Therapeutics (ASCPT) Meeting

The results from two positive bioavailability studies, previously reported by the Company, demonstrate the safety and tolerability of BEKINDA™ and support the European marketing application...
February 13, 2015 10:18 ET | Source: RedHill Biopharma Ltd.

RedHill Biopharma Announces Closing of Public Offering of Its American Depository Shares

TEL-AVIV, Israel, Feb. 13, 2015 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) ("RedHill" or the "Company"), an Israeli biopharmaceutical company primarily focused on late...
April 30, 2014 07:00 ET | Source: RedHill Biopharma Ltd.

RedHill Biopharma Reports Successful RHB-102 Bioavailability Clinical Trial and Planned Submission of European Marketing Application in Q3/2014

RedHill received positive results from a comparative bioavailability clinical trial which included 20 healthy volunteers In light of the positive results, and subject to regulatory...